Valeo Financial Advisors, LLC Eli Lilly & CO Transaction History

Valeo Financial Advisors, LLC

$3.81 Billion
Q3 2024

A detailed history of Valeo Financial Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Valeo Financial Advisors, LLC holds 113,750 shares of LLY stock, worth $87.3 Million. This represents 2.64% of its overall portfolio holdings.

Number of Shares

113,750

Previous 112,545 1.07%

Holding current value

$87.3 Million

Previous $102 Million 1.1%

% of portfolio

2.64%

Previous 2.92%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$772.14 - $960.02 $930,428 - $1.16 Million	1,205 Added 1.07%	113,750 $101 Million
Q2 2024 Jul 10, 2024	BUY	$724.87 - $909.04 $1.76 Million - $2.21 Million	2,432 Added 2.21%	112,545 $102 Million
Q1 2024 Apr 25, 2024	BUY	$592.2 - $792.28 $2.65 Million - $3.54 Million	4,467 Added 4.23%	110,113 $85.7 Million
Q1 2024 Apr 19, 2024	BUY	$592.2 - $792.28 $689,913 - $923,006	1,165 Added 1.12%	105,646 $82.2 Million
Q4 2023 Jan 29, 2024	BUY	$525.19 - $619.13 $429,605 - $506,448	818 Added 0.79%	104,481 $60.9 Million
Q3 2023 Oct 19, 2023	BUY	$434.7 - $599.3 $121,281 - $167,204	279 Added 0.27%	103,663 $55.7 Million
Q2 2023 Jul 14, 2023	BUY	$350.74 - $468.98 $10.3 Million - $13.7 Million	29,273 Added 39.5%	103,384 $48.5 Million
Q1 2023 Apr 17, 2023	BUY	$310.63 - $364.82 $2.91 Million - $3.42 Million	9,367 Added 14.47%	74,111 $25.5 Million
Q4 2022 Feb 09, 2023	BUY	$321.55 - $374.67 $171,707 - $200,073	534 Added 0.83%	64,744 $23.7 Million
Q3 2022 Oct 31, 2022	BUY	$296.48 - $337.87 $684,868 - $780,479	2,310 Added 3.73%	64,210 $20.8 Million
Q2 2022 Aug 03, 2022	SELL	$278.73 - $327.27 $2.76 Million - $3.24 Million	-9,906 Reduced 13.8%	61,900 $20.1 Million
Q1 2022 Apr 28, 2022	BUY	$234.69 - $291.66 $2.12 Million - $2.64 Million	9,038 Added 14.4%	71,806 $20.6 Million
Q4 2021 Jan 07, 2022	BUY	$224.85 - $279.04 $341,772 - $424,140	1,520 Added 2.48%	62,768 $17.3 Million
Q3 2021 Nov 02, 2021	BUY	$221.6 - $272.71 $912,548 - $1.12 Million	4,118 Added 7.21%	61,248 $14.2 Million
Q2 2021 Jul 22, 2021	BUY	$180.55 - $233.54 $505,178 - $653,444	2,798 Added 5.15%	57,130 $13.1 Million
Q1 2021 Apr 12, 2021	BUY	$164.32 - $212.72 $16,103 - $20,846	98 Added 0.18%	54,332 $10.2 Million
Q4 2020 Feb 11, 2021	BUY	$130.46 - $172.63 $1.72 Million - $2.27 Million	13,165 Added 32.06%	54,234 $9.16 Million
Q3 2020 Oct 28, 2020	SELL	$146.22 - $169.13 $74,718 - $86,425	-511 Reduced 1.23%	41,069 $6.08 Million
Q2 2020 Jul 20, 2020	SELL	$136.42 - $164.18 $19,917 - $23,970	-146 Reduced 0.35%	41,580 $6.83 Million
Q1 2020 Apr 13, 2020	SELL	$119.05 - $147.35 $981,091 - $1.21 Million	-8,241 Reduced 16.49%	41,726 $6.08 Million
Q4 2019 Jan 24, 2020	BUY	$106.92 - $132.43 $721,175 - $893,240	6,745 Added 15.61%	49,967 $6.57 Million
Q3 2019 Oct 15, 2019	SELL	$106.79 - $116.16 $792,061 - $861,558	-7,417 Reduced 14.65%	43,222 $4.83 Million
Q2 2019 Jul 10, 2019	SELL	$110.79 - $129.32 $6,425 - $7,500	-58 Reduced 0.11%	50,639 $5.61 Million
Q1 2019 Apr 12, 2019	BUY	$111.31 - $131.02 $580,259 - $683,007	5,213 Added 11.46%	50,697 $6.58 Million
Q4 2018 Jan 30, 2019	SELL	$105.9 - $118.64 $135,340 - $151,621	-1,278 Reduced 2.73%	45,484 $5.26 Million
Q3 2018 Nov 01, 2018	SELL	$85.86 - $107.31 $321,373 - $401,661	-3,743 Reduced 7.41%	46,762 $5.07 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $1.63 Million - $1.88 Million	-21,597 Reduced 29.95%	50,505 $5.17 Million
Q1 2018 Apr 12, 2018	BUY	$74.21 - $87.6 $787,739 - $929,873	10,615 Added 17.26%	72,102 $5.58 Million
Q4 2017 Feb 09, 2018	BUY	$81.94 - $87.89 $1.72 Million - $1.85 Million	21,002 Added 51.88%	61,487 $5.19 Million
Q3 2017 Nov 15, 2017	BUY	$77.07 - $85.54 $7,706 - $8,554	100 Added 0.25%	40,485 $3.46 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $3.11 Million - $3.45 Million	40,385	40,385 $3.46 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Valeo Financial Advisors, LLC with notifications on news.

Account

Valeo Financial Advisors, LLC Eli Lilly & CO Transaction History